GLYC News and Press, GlycoMimetics Inc. From 09/07/22

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that Harout Semerjian, Chief Executive Officer, will present in-person at the H.C. Wainwright 24 th Annual Global Investment Conference in New York, NY on Wednesday, September 14, 2022 at 3:00 p.m. ET. An archived recording of t...

GlycoMimetics ( NASDAQ: GLYC ) appoints nearly two decades of biopharmaceutical clinical development experienced Edwin Rock, M.D., Ph.D. as Chief Medical Officer (CMO). Most recently Edwin Rock served as CMO for Partner Therapeutics, a privately-held co...

GlycoMimetics, Inc. (Nasdaq: GLYC), a clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced that Edwin Rock, M.D., Ph.D. has joined the executive leadership team as Chief Medical Officer (CMO)....

GlycoMimetics, Inc. (GLYC) Q2 2022 Earnings Conference Call August 03, 2022 08:30 AM ET Company Participants Christian Dinneen-Long - Company Counsel Harout Semerjian - Chief Executive Officer Brian Hahn - Chief Financial Officer Bruce Johnson - Chief Commerc...

Image source: The Motley Fool. GlycoMimetics (NASDAQ: GLYC) Q2 2022 Earnings Call Aug 03, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: GlycoMimetics (GLYC) Q2 2022 Earnings Call Transcript

GlycoMimetics press release ( NASDAQ: GLYC ): Q2 GAAP EPS of $0.25 beats by $0.53 . Revenue of $75K. Cash and cash equivalents as of the end of the quarter were $60.2 million For further details see: GlycoMimetics GAAP EPS of $0.25 beats by $0.53, revenue...

U.S. Food and Drug Administration (FDA) Clearance of Investigational New Drug (IND) application to study GMI-1687 in Sickle Cell Disease (SCD) received in June The Company previously disclosed and will continue to update its projection of mid-year 2023 for the survival events trig...

ABC , ALE , OTCPK:AMKBY , AMRN , AROC , ATHM , AVA , AY , BCO , BDC , BERY , BFLY , BGCP , BIP , OTCPK:BMWYY , BRSP , BRY , BWA , CARS , CCRD , CDW , CLDT , CLH , CRL , CRTO , CSTE , ...

GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report second quarter financial results on Wednesday, August 3, 2022, at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you will be provided...

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that the Company will participate at the Jefferies 2022 Healthcare Conference, on June 8 th , in New York, NY. Chief Executive Officer Harout Semerjian and Chief Financial Officer Brian Hahn will attend in person. Research Analy...